The Oncology Institute Inc TOI

$5.13 +0.27 (5.56%)

Valuation

Market cap
507,044,000
Revenue TTM
$502,730,000
Net income TTM
$-60,610,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-12.06%
Debt to equity
-4.83

Trading

Volume
1,265,500
Avg volume
1,900,142
Day's range
$4.87 – $5.15
Shares out
98,839,000
Stochastic %K
52%
Beta
0.39
Analysts
Moderate Buy
Price target
$8.50

Price

Company profile

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, su...

Show more

The Oncology Institute, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Industry
Medical Care Facilities
Sector
Healthcare
Phone
562 735 3226
Website
https://theoncologyinstitute.com
Address
18000 Studebaker Road, Suite 800, Cerritos, United States

Latest news

No headlines yet.